Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Development of 5-Fluorouracil Derivatives as Anticancer Agents

Author(s): Xiaoyan Pan, Chen Wang, Fang Wang, Pengfei Li, Zhigang Hu, Yuanyuan Shan and Jie Zhang

Volume 18, Issue 29, 2011

Page: [4538 - 4556] Pages: 19

DOI: 10.2174/092986711797287584

Price: $65

Abstract

5-Fluorouracil (5-FU) is one of the most potent antimetabolites which have been widely used in the treatment of advanced solid tumors. As an anticancer agent, because of its low efficacy and high toxicity, numerous modifications of 5-FU structure have been performed. A great number of novel 5-FU derivatives have been developed with highly efficient and much less toxic. In this paper, the recent development of novel 5-FU derivatives as potent antitumor agents is reviewed and discussed.

Keywords: 5-Fluorouracil (5-FU), anticancer, thymidylate synthase, antimetabolite, toxicity, tumor, derivative, macromolecule, pyrimidine, polymer


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy